APHLX | VIVIX | APHLX / VIVIX | |
Total Expense Ratio | 0.84 | 0.04 | 2,100% |
Annual Report Gross Expense Ratio | 0.86 | 0.04 | 2,150% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 8.479 | 6.730 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 323M | 195B | 0% |
Annual Yield % from dividends | 1.37 | 2.19 | 62% |
Returns for 1 year | 6.88 | 9.75 | 71% |
Returns for 3 years | 20.11 | 34.32 | 59% |
Returns for 5 years | 34.93 | 74.87 | 47% |
Returns for 10 years | 32.80 | 116.26 | 28% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CRED | 22.00 | 0.32 | +1.45% |
Columbia Research Enhanced Rl Estt ETF | |||
DIVB | 51.33 | 0.19 | +0.37% |
iShares Core Dividend ETF | |||
OMFS | 40.87 | 0.11 | +0.26% |
Invesco Russell 2000® Dynamic Mltfct ETF | |||
CGUI | 25.30 | 0.01 | +0.04% |
Capital Group Ultra Short Income ETF | |||
XISE | 30.42 | 0.01 | +0.03% |
FT Vest US Eq Buf & Prm IncETF-Sept |